No. |
Product Name |
CAS No. |
Spec |
Price |
|
| 1457083 |
Naphthalene (200 mg) |
91-20-3 |
|
|
| 1457301 |
Naproxen (200 mg) |
22204-53-1 |
|
|
| 1457403 |
Naproxen Sodium (200 mg) |
26159-34-2 |
|
|
| 1457458 |
Narasin (125 mg) |
55134-13-9 |
|
|
| 1457469 |
Naratriptan Hydrochloride (125 mg) |
143388-64-1 |
|
|
| 1457491 |
Naratriptan Resolution Mixture (20 mg) |
N/A |
|
|
| 1457505 |
Natamycin (200 mg) |
7681-93-8 |
|
|
| 1457607 |
Nateglinide (200 mg) |
105816-04-4 |
|
|
| 1457618 |
Nateglinide Related Compound A (10 mg) (trans-4-isopropylcyclohexanecarboxylic acid) |
7077-05-6 |
|
|
| 1457629 |
Nateglinide Related Compound B (10 mg) (N-(trans-4-isopropylcyclohexanecarbonyl)-L-phenylalanine) |
105816-05-5 |
|
|
| 1457630 |
Nateglinide Related Compound C (5 mg) (N-(cis-4-isopropylcyclohexanecarbonyl)-D-phenylalanine) |
105816-06-6 |
|
|
| 1457844 |
Near IR System Suitability |
N/A |
|
|
| 1457902 |
Nefazodone Hydrochloride (200 mg) |
82752-99-6 |
|
|
| 1457913 |
Nefazodone Related Compound A (25 mg) (1-(3-chlorophenyl)-4-(3-chloropropyl)-piperazine hydrochloride) |
57059-62-8 |
|
|
| 1457924 |
Nefazodone Related Compound B (25 mg) (2-[3-[4-(4-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride) |
N/A |
|
|
| 1457968 |
Nelfinavir Mesylate (200 mg) |
159989-64-7 (hydrate); 159989- |
|
|
| 1457979 |
Nelfinavir Related Compound A (15 mg) ((3S,4aS,8aS)-N-tert-Butyl-2-[(2R,3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylsulfinyl)butyl]decahydroisoquinoline-3-carboxamide) |
1041389-28-9 |
|
|
| 1458009 |
Neomycin Sulfate (200 mg) |
1405-10-3 |
|
|
| 1458053 |
Neohesperidine Dihydrochalcone (100 mg) |
20702-77-6 |
|
|
| 1459001 |
Neostigmine Bromide (200 mg) |
114-80-7 |
|
|
